Clinical Trial

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2024 (before its estimated December 11, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.
Trial Details
NCT Number NCT06724861
Lead Sponsor Assaf-Harofeh Medical Center
Collaborators: Zefat Academic College
Conditions CIPN - Chemotherapy-Induced Peripheral Neuropathy, Age Over 18, Chemotherapy-induced Peripheral Neuropathy
Enrollment 27 participants
Start Date 2024-12-11
Primary Completion 2024-12-11 (estimated)
Study Completion 2026-12-11 (estimated)
Updated on ClinicalTrials.gov 2024-12-09